no the subgroup of experimental patients that achieve a 50% improvement in VAS and ODI (already clincially significant by defnitintion) just needs to be stat more significant than the control group. In the P2 trial, this was pissed in as per our previous review in December....
https://hotcopper.com.au/posts/49740687/single
https://hotcopper.com.au/posts/49740572/single
MPC-06-ID Phase 3 results countdown, page-195
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
-0.025(1.86%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.35 | $1.31 | $2.699M | 2.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34995 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 10374 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |